The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome ...

The Association of Resident Doctors, Federal Capital Territory Administration, ARD FCTA, has commenced a three-day warning ...